guidanc follow strong result initi guidanc host
quarterli earn call tuesday morn provid addit
clariti item embed guidanc first ep guidanc
exclud prior year develop pyd context benefit
second ep guidanc assum benefit risk adjust true-up
ep benefit third ep guidanc absorb strand
cost relat medicaid contract loss fl nm consolid net margin
emb follow margin assumpt medicaid margin flat y/i
medicar margin basi point marketplac margin bp
adjust non-cash amort adjust ep impli
guidanc notabl higher street ep estim
view posit given investor focu earn sustain
throughout potenti conservat guid describ
stock reaction despit posit ep guidanc stock trade sharpli
back renew concern around moh top-lin growth understand concern
around low top-lin visibl play role ew rate
sinc initi coverag juli virtual stock ow rate
coverag howev today neg reaction appear overdon particularli sinc
guidanc materi chang view moh growth profil
beyond view bn revenue guidanc slightli disappoint
compar bn estim revenu headwind known
time last month investor present ceo zubretski note
sign-up jan track rang would point materi
declin exchang membership peak membership even
disclosur stock still ralli follow jan present told
rais ep ep
pt base price-to-earnings higher ep
quarterli annual ep usd
rais usd
return equiti ttm
link barclay live interact chart
consensu number refinitiv receiv gmt
barclay capit inc and/or one affili seek busi
compani cover research report result investor awar
firm may conflict interest could affect object report investor
consid report singl factor make invest decis
margin return data
balanc sheet cash flow mn
equival
short long-term debt
chang work capit
flow oper
valuat leverag metric
equal weight price target base
price-to-earnings ep reflect uncertainti
sustain margin exchang
lower visibl growth
upsid case reflect higher sustain
margin exchang addit cost save
upsid potenti greater membership growth
across medicaid medicar marketplac
downsid case reflect margin compress
exchang inabl harvest addit cost
save potenti membership loss
medicaid marketplac segment lead
compani report barclay research net intang amort
high mid y/i y/i vs vs revenu loss ratio bpsnm bpsnmadjust sg bpsnm bpsnmeffect tax rate bpsnmdilut share mn ep amort intang adjust ep per ca medicaid expans retroact revenu marketplac risk adjust marketplac csr loss sale restructur loss debt adjust oper ep barclay
guidanc earn premium bnpremium tax mninvest incom mntotal bnmedic care bnmedic care administr bng tax mndepreci mninterest expens expens mnincom incom mn mnnet mn mn mneffect tax weight averag mnnet incom per net incom per medicar mnmarketplac barclay
product busi segment medicaid member growthtanf medicaid producttanf medicaid changetanf medicaid producttanf medicaid premium changetanf medicaid premium barclay
quarterli incom statement mil ep ep ep tax insur fee hif premium incom changepremium tax insur fee hif premium incom medic loss ratio gross insur py tax incom /expens addback intang ebitda margin ex inv expens exclud expens incom ebit ebit margin ex inv expens incom rate rate ex-hif minor interest/discontinu barclay
steve valiquett herebi certifi view express research report accur reflect person view
subject secur issuer refer research report part compens directli indirectli relat
specif recommend view express research report
barclay research produc invest bank barclay bank plc affili collect individu barclay
author contribut research report research analyst unless otherwis indic public date top report
reflect local time report produc may differ releas date provid gmt
avail disclosur
compani subject research report current import disclosur regard compani pleas refer
http //publicresearch barclay com altern send written request barclay research complianc seventh avenu floor
new york ny call
analyst respons prepar research report receiv compens base upon variou factor includ firm total
revenu portion gener invest bank activ profit revenu market busi
potenti interest firm invest client research respect asset class cover analyst
analyst regularli conduct site visit view materi oper cover compani barclay polici prohibit accept
payment reimburs cover compani travel expens visit
barclay research depart produc variou type research includ limit fundament analysi equity-link analysi
quantit analysi trade idea recommend contain one type barclay research may differ contain
type barclay research whether result differ time horizon methodolog otherwis
http //publicresearch barcap com/s/rd htm order access barclay research conflict manag polici statement pleas refer
procedur pleas
price sourc refinitiv last avail close price relev trade market unless anoth time sourc indic
